TRACON Pharmaceuticals Inc (TCON)
1.29
+0.04
(+3.20%)
USD |
NASDAQ |
May 31, 16:00
1.29
0.00 (0.00%)
After-Hours: 20:00
TRACON Pharmaceuticals Profit Margin (Quarterly): -3.17K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -3.17K% |
December 31, 2023 | 14.42% |
September 30, 2023 | |
June 30, 2023 | -69.84% |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | -2.58K% |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 |
Date | Value |
---|---|
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | -278.8% |
December 31, 2017 | |
September 30, 2017 | 15.60% |
June 30, 2017 | -1.04K% |
March 31, 2017 | -1.14K% |
December 31, 2016 | -1.02K% |
September 30, 2016 | -720.4% |
June 30, 2016 | -1.03K% |
March 31, 2016 | -539.3% |
December 31, 2015 | -791.9% |
September 30, 2015 | -546.4% |
June 30, 2015 | -69.60% |
March 31, 2015 | -352.9% |
December 31, 2014 | -245.1% |
September 30, 2014 | -169.4% |
June 30, 2014 | -91.67% |
March 31, 2014 | -382.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.17K%
Minimum
Mar 2024
14.42%
Maximum
Dec 2023
-1.45K%
Average
-1.33K%
Median
Profit Margin (Quarterly) Benchmarks
BioSig Technologies Inc | -24.30K% |
Revolution Medicines Inc | -- |
Perspective Therapeutics Inc | -- |
Electromed Inc | 10.76% |
Xtant Medical Holdings Inc | -15.79% |
Profit Margin (Quarterly) Related Metrics
Return on Assets | 17.70% |
Operating Margin (Quarterly) | -3.21K% |
Return on Net Operating Assets | 86.48% |